Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Apr 14, 2021, 5:09 a.m.

/zigman2/quotes/209129655/composite

$

18.29

Change

-0.03 -0.16%

Volume

Volume 7,976

Real time quotes

/zigman2/quotes/209129655/composite

Previous close

$ 18.32

$ 18.32

Change

+1.13 +6.57%

Day low

Day high

$16.28

$18.53

Open

52 week low

52 week high

$4.41

$67.00

Open

Company Description

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extract...

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Valuation

Price to Sales Ratio

4.95

Price to Book Ratio

3.50

Enterprise Value to Sales

5.67

Total Debt to Enterprise Value

0.29

Efficiency

Revenue/Employee

204,351.00

Income Per Employee

-263,178.00

Receivables Turnover

5.00

Total Asset Turnover

0.23

Liquidity

Current Ratio

1.91

Quick Ratio

1.40

Cash Ratio

1.05

Profitability

Gross Margin

5.45

Operating Margin

-60.49

Pretax Margin

-128.61

Net Margin

-128.79

Return on Assets

-29.43

Return on Equity

-82.25

Return on Total Capital

-17.33

Return on Invested Capital

-37.10

Capital Structure

Total Debt to Total Equity

91.28

Total Debt to Total Capital

47.72

Total Debt to Total Assets

36.08

Long-Term Debt to Equity

90.10

Long-Term Debt to Total Capital

47.10

Officers and Executives

Name Age Officer Since Title
Mr. Brendan Kennedy 47 2018 President, Chief Executive Officer & Director
Mr. Jon Levin 50 2020 Chief Operating Officer
Mr. Michael Kruteck 57 2020 Chief Financial Officer
Dr. Joshua Eades - 2014 Chief Science Officer & Vice President
Mr. Michael Auerbach 42 - Director

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/01/2021 Michael B. Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
03/18/2021 Andrew Pucher
Chief Corporate Dev Officer
3,495   Derivative/Non-derivative trans. at $0 per share. 0
03/18/2021 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
03/16/2021 Michael B. Shtender-Auerbach
Director
31,164   0
03/16/2021 Michael B. Shtender-Auerbach
Director
73,593   0
03/16/2021 Michael B. Shtender-Auerbach
Director
268,095   0
03/16/2021 Michael B. Shtender-Auerbach
Director
685,424   0
03/05/2021 Michael Kruteck
Chief Financial Officer
14,646   Derivative/Non-derivative trans. at $0 per share. 0
03/05/2021 Jon Levin
Chief Operating Officer
15,830   Derivative/Non-derivative trans. at $0 per share. 0
03/05/2021 Michael Kruteck
Chief Financial Officer
33,360   Award at $0 per share. 0
03/05/2021 Jon Levin
Chief Operating Officer
33,360   Award at $0 per share. 0
03/01/2021 Rebekah Dopp
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2021 Christine Thompson St. Clare
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
02/23/2021 Michael B. Shtender-Auerbach
Director
5,929   0
02/23/2021 Michael B. Shtender-Auerbach
Director
20,392   0
02/23/2021 Michael B. Shtender-Auerbach
Director
89,349   0
02/23/2021 Michael B. Shtender-Auerbach
Director
228,433   0
02/19/2021 Michael Kruteck
Chief Financial Officer
23,476   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2021 Jon Levin
Chief Operating Officer
26,982   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2021 Michael Kruteck
Chief Financial Officer
53,191   Award at $0 per share. 0
02/19/2021 Jon Levin
Chief Operating Officer
56,738   Award at $0 per share. 0
01/25/2021 Brendan Kennedy
President and CEO; Director
57   0
01/25/2021 Brendan Kennedy
President and CEO; Director
3,371   0
01/25/2021 Michael B. Shtender-Auerbach
Director
202   0
01/25/2021 Michael B. Shtender-Auerbach
Director
517   0
01/25/2021 Michael B. Shtender-Auerbach
Director
116   0
01/01/2021 Brendan Kennedy
President and CEO; Director
12,777   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Michael B. Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
12/18/2020 Michael B. Shtender-Auerbach
Director
3,595   0
12/18/2020 Michael B. Shtender-Auerbach
Director
13,895   0
12/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
12/18/2020 Michael B. Shtender-Auerbach
Director
61,289   0
12/18/2020 Michael B. Shtender-Auerbach
Director
156,693   0
12/18/2020 Andrew Pucher
Chief Corporate Dev Officer
3,303   Derivative/Non-derivative trans. at $0 per share. 0
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. Marijuana Stock Aphria Tanks After Net Loss Widens

    11:20 a.m. April 12, 2021

    - Connor Smith

  2. Pot Producer Green Thumb Reports Strong Earnings

    6:13 p.m. March 17, 2021

    - Bill Alpert

  3. Why Curaleaf Is Upbeat About Cannabis Reform

    4:00 p.m. March 10, 2021

    - Bill Alpert

  4. Pot or Alcohol, Barron’s Has Never Favored Prohibition

    5:30 a.m. March 4, 2021

    - Kenneth G. Pringle

  5. Tilray stock price target raised to $21.00 from $9.20 at Stifel Nicolaus

    7:35 a.m. Feb. 23, 2021

    - Tomi Kilgore

  6. Marijuana Stock Tilray Is Rising. A Bull Is Stepping Aside.

    12:32 p.m. Feb. 18, 2021

    - Connor Smith

  7. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. Aphria Gets Smoked On Surprisingly Awful Earnings

    4:16 p.m. April 13, 2021

    - InvestorPlace.com

  2. Aphria Investors Are Just Waiting On the Votes to Be Counted

    2:50 p.m. April 13, 2021

    - InvestorPlace.com

  3. OGI, TLRY, APHA among premarket losers

    8:31 a.m. April 13, 2021

    - Seeking Alpha

  4. Will HEXO's "Bake Sale" Ruin Its Chances of Posting a Profit?

    6:15 a.m. April 13, 2021

    - Motley Fool

  5. Why Marijuana Stocks Went to Pot Monday

    5:40 p.m. April 12, 2021

    - Motley Fool

  6. Here's Why Investors Hated Aphria's Q3 Results

    10:40 a.m. April 12, 2021

    - Motley Fool

  7. Why Aphria and Tilray Stocks Are Tanking Today

    10:28 a.m. April 12, 2021

    - Motley Fool

  8. The Aphria Merger Will Change Everything For Tilray

    10:26 a.m. April 12, 2021

    - InvestorPlace.com

  9. APHA Stock: The Big Covid-19 Toll Sending Aphria Stumbling Today

    9:23 a.m. April 12, 2021

    - InvestorPlace.com

  10. ICICI Bank, Tata Motors among premarket losers' pack

    8:45 a.m. April 12, 2021

    - Seeking Alpha

  11. Wall Street Breakfast: Alibaba Relief

    7:17 a.m. April 12, 2021

    - Seeking Alpha

  12. Wall Street Breakfast: The Week Ahead

    7:03 a.m. April 11, 2021

    - Seeking Alpha

  13. Seeking Alpha Catalyst Watch

    1:30 p.m. April 9, 2021

    - Seeking Alpha

  14. 3 Best Marijuana Stocks so Far This Year: Are They Buys Now?

    6:01 a.m. April 9, 2021

    - Motley Fool

  15. Loading more headlines...

At a Glance

Tilray, Inc.

1100 Maughan Road

Nanaimo, British Columbia V9X IJ2

Phone

1 8448457291

Industry

Farming

Sector

Agriculture

Fiscal Year-end

12/2021

Revenue

$210.48M

Net Income

$-271.07M

2020 Sales Growth

26.1%

Employees

1,030

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Global M&A Activity on the Rise Again in the Cannabis Sector

    9:02 a.m. April 9, 2021

    - Financial News Media

  2. Global M&A Activity on the Rise Again in the Cannabis Sector

    9:00 a.m. April 9, 2021

    - PR Newswire - PRF

  3. Canopy Growth Buys Rival Supreme Cannabis For $435 Million

    6:45 a.m. April 9, 2021

    - Baystreet.ca

  4. Companies Partner with Researchers to Identify New Uses of Hemp Products

    8:51 a.m. March 25, 2021

    - Financial News Media

  5. Best Stocks To Buy Now? 4 Cannabis Stocks To Know

    10:55 a.m. March 18, 2021

    - StockMarket.com

  6. The US CBD Market Could be Worth $3 Billion By 2023

    9:15 a.m. March 18, 2021

    - Baystreet.ca

  7. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.